Esperion Therapeutics
Audrey Andison is an accomplished finance professional with extensive experience in accounting and financial reporting. Currently serving as the Controller at Esperion since June 2016, Audrey has held various key roles within the company, including Assistant Controller, Senior Accounting Manager, and Financial Reporting Manager. Prior to joining Esperion, Audrey was an Assurance Senior Associate at PwC from August 2010 to June 2016. Audrey holds both a Master of Science (M.S.) in Accounting and a Bachelor of Arts (B.A.) in Accounting from Michigan State University - Eli Broad College of Business, completing the master's degree in 2010 and the bachelor's degree in 2009.
This person is not in any offices
Esperion Therapeutics
2 followers
Through scientific and clinical excellence, and a deep understanding of cholesterol biology, the experienced Lipid Management Team at ESPERION is committed to developing new LDL-C lowering medicines that will make a substantial impact on reducing global cardiovascular disease, the leading cause of death around the world.